US Stock MarketDetailed Quotes

CNSP CNS Pharmaceuticals

Watchlist
  • 0.1800
  • -0.0150-7.69%
Close Aug 26 16:00 ET
  • 0.1819
  • +0.0019+1.06%
Post 16:35 ET
5.79MMarket Cap-1P/E (TTM)

CNS Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
51.50%-1.65M
33.84%-3.19M
-33.93%-14.14M
-10.02%-2.54M
-86.25%-3.38M
-1.20%-3.4M
-56.79%-4.82M
22.02%-10.56M
28.78%-2.31M
9.16%-1.81M
Net income from continuing operations
37.07%-2.53M
28.13%-3.54M
-23.42%-18.85M
-4.64%-5.38M
-32.26%-4.52M
-12.77%-4.02M
-56.48%-4.93M
-5.37%-15.27M
-57.87%-5.14M
10.35%-3.42M
Operating gains losses
--0
---190
-83.99%498
-154.41%-259
----
----
----
--3.11K
--476
--1.17K
Depreciation and amortization
-25.02%752
-36.04%818
-64.83%4.13K
-59.97%953
-67.82%899
-68.71%1K
-62.10%1.28K
-10.05%11.76K
-31.84%2.38K
-17.07%2.79K
Change In working capital
96.85%645.26K
180.94%149.13K
16.90%3.7M
18.17%2.61M
-27.65%950.06K
472.09%327.79K
30.60%-184.24K
505.67%3.16M
826.64%2.2M
0.33%1.31M
-Change in prepaid assets
-188.70%-116.06K
-85.12%102.99K
176.28%2.38M
391.67%800.26K
-13.89%753.94K
322.43%130.85K
117.60%692.22K
156.60%860.45K
-86.62%-274.37K
87.66%875.53K
-Change in payables and accrued expense
286.57%761.32K
105.26%46.14K
-42.62%1.32M
-27.18%1.81M
-55.18%196.12K
772.87%196.94K
-50.18%-876.46K
211.23%2.3M
1,685.14%2.48M
-38.34%437.58K
Cash from discontinued investing activities
Operating cash flow
51.50%-1.65M
33.84%-3.19M
-33.93%-14.14M
-10.02%-2.54M
-86.25%-3.38M
-1.20%-3.4M
-56.79%-4.82M
22.02%-10.56M
28.78%-2.31M
9.16%-1.81M
Investing cash flow
Cash flow from continuing investing activities
11.78%-3.9K
-215,800.00%-2.16K
23.07%-4.42K
100.05%1
-1.51K
Net PPE purchase and sale
----
----
11.78%-3.9K
-215,800.00%-2.16K
----
----
----
23.07%-4.42K
100.05%1
---1.51K
Cash from discontinued investing activities
Investing cash flow
----
----
11.78%-3.9K
-215,800.00%-2.16K
----
----
----
23.07%-4.42K
100.05%1
---1.51K
Financing cash flow
Cash flow from continuing financing activities
-9.52%2.33M
2,975.33%3.46M
-70.30%4.64M
-59.17%2.18M
107.14%8.36K
2,313.46%2.57M
-101.14%-120.28K
246.26%15.61M
6,538.96%5.33M
-103.41%-117.14K
Net issuance payments of debt
26.76%-89.86K
27.45%-87.7K
-2.58%-438.73K
10.73%-70.67K
-6.28%-124.49K
-5.60%-122.68K
-4.92%-120.89K
10.43%-427.7K
4.42%-79.17K
11.89%-117.14K
Net common stock issuance
23.12%2.42M
--3.53M
-85.55%2.32M
-96.02%215.64K
--132.85K
--1.97M
--0
244.62%16.04M
--5.41M
--0
Proceeds from stock option exercised by employees
-98.77%8.92K
1,936.95%12.41K
108,211.59%2.96M
1,894,451.69%2.24M
--0
--725.06K
-76.72%609
-99.18%2.73K
--118
--0
Net other financing activities
----
----
---202.86K
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-9.52%2.33M
2,975.33%3.46M
-70.30%4.64M
-59.17%2.18M
107.14%8.36K
2,313.46%2.57M
-101.14%-120.28K
246.26%15.61M
6,538.96%5.33M
-103.41%-117.14K
Net cash flow
Beginning cash position
-84.05%815.23K
-94.54%548.72K
100.93%10.06M
-87.06%909.55K
-52.23%4.28M
-58.92%5.11M
100.93%10.06M
-64.35%5M
-15.60%7.03M
30.11%8.96M
Current changes in cash
181.36%676.33K
105.39%266.51K
-288.22%-9.51M
-111.92%-360.83K
-74.47%-3.37M
76.12%-831.28K
-166.50%-4.94M
155.90%5.05M
191.16%3.03M
-234.07%-1.93M
End cash Position
-65.14%1.49M
-84.05%815.23K
-94.54%548.72K
-94.54%548.72K
-87.06%909.55K
-52.23%4.28M
-58.92%5.11M
100.93%10.06M
100.93%10.06M
-15.60%7.03M
Free cash flow
51.50%-1.65M
33.84%-3.19M
-33.91%-14.14M
-10.12%-2.54M
-86.19%-3.38M
-1.11%-3.4M
-56.79%-4.82M
22.02%-10.56M
28.82%-2.31M
9.08%-1.81M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 51.50%-1.65M33.84%-3.19M-33.93%-14.14M-10.02%-2.54M-86.25%-3.38M-1.20%-3.4M-56.79%-4.82M22.02%-10.56M28.78%-2.31M9.16%-1.81M
Net income from continuing operations 37.07%-2.53M28.13%-3.54M-23.42%-18.85M-4.64%-5.38M-32.26%-4.52M-12.77%-4.02M-56.48%-4.93M-5.37%-15.27M-57.87%-5.14M10.35%-3.42M
Operating gains losses --0---190-83.99%498-154.41%-259--------------3.11K--476--1.17K
Depreciation and amortization -25.02%752-36.04%818-64.83%4.13K-59.97%953-67.82%899-68.71%1K-62.10%1.28K-10.05%11.76K-31.84%2.38K-17.07%2.79K
Change In working capital 96.85%645.26K180.94%149.13K16.90%3.7M18.17%2.61M-27.65%950.06K472.09%327.79K30.60%-184.24K505.67%3.16M826.64%2.2M0.33%1.31M
-Change in prepaid assets -188.70%-116.06K-85.12%102.99K176.28%2.38M391.67%800.26K-13.89%753.94K322.43%130.85K117.60%692.22K156.60%860.45K-86.62%-274.37K87.66%875.53K
-Change in payables and accrued expense 286.57%761.32K105.26%46.14K-42.62%1.32M-27.18%1.81M-55.18%196.12K772.87%196.94K-50.18%-876.46K211.23%2.3M1,685.14%2.48M-38.34%437.58K
Cash from discontinued investing activities
Operating cash flow 51.50%-1.65M33.84%-3.19M-33.93%-14.14M-10.02%-2.54M-86.25%-3.38M-1.20%-3.4M-56.79%-4.82M22.02%-10.56M28.78%-2.31M9.16%-1.81M
Investing cash flow
Cash flow from continuing investing activities 11.78%-3.9K-215,800.00%-2.16K23.07%-4.42K100.05%1-1.51K
Net PPE purchase and sale --------11.78%-3.9K-215,800.00%-2.16K------------23.07%-4.42K100.05%1---1.51K
Cash from discontinued investing activities
Investing cash flow --------11.78%-3.9K-215,800.00%-2.16K------------23.07%-4.42K100.05%1---1.51K
Financing cash flow
Cash flow from continuing financing activities -9.52%2.33M2,975.33%3.46M-70.30%4.64M-59.17%2.18M107.14%8.36K2,313.46%2.57M-101.14%-120.28K246.26%15.61M6,538.96%5.33M-103.41%-117.14K
Net issuance payments of debt 26.76%-89.86K27.45%-87.7K-2.58%-438.73K10.73%-70.67K-6.28%-124.49K-5.60%-122.68K-4.92%-120.89K10.43%-427.7K4.42%-79.17K11.89%-117.14K
Net common stock issuance 23.12%2.42M--3.53M-85.55%2.32M-96.02%215.64K--132.85K--1.97M--0244.62%16.04M--5.41M--0
Proceeds from stock option exercised by employees -98.77%8.92K1,936.95%12.41K108,211.59%2.96M1,894,451.69%2.24M--0--725.06K-76.72%609-99.18%2.73K--118--0
Net other financing activities -----------202.86K----------------------------
Cash from discontinued financing activities
Financing cash flow -9.52%2.33M2,975.33%3.46M-70.30%4.64M-59.17%2.18M107.14%8.36K2,313.46%2.57M-101.14%-120.28K246.26%15.61M6,538.96%5.33M-103.41%-117.14K
Net cash flow
Beginning cash position -84.05%815.23K-94.54%548.72K100.93%10.06M-87.06%909.55K-52.23%4.28M-58.92%5.11M100.93%10.06M-64.35%5M-15.60%7.03M30.11%8.96M
Current changes in cash 181.36%676.33K105.39%266.51K-288.22%-9.51M-111.92%-360.83K-74.47%-3.37M76.12%-831.28K-166.50%-4.94M155.90%5.05M191.16%3.03M-234.07%-1.93M
End cash Position -65.14%1.49M-84.05%815.23K-94.54%548.72K-94.54%548.72K-87.06%909.55K-52.23%4.28M-58.92%5.11M100.93%10.06M100.93%10.06M-15.60%7.03M
Free cash flow 51.50%-1.65M33.84%-3.19M-33.91%-14.14M-10.12%-2.54M-86.19%-3.38M-1.11%-3.4M-56.79%-4.82M22.02%-10.56M28.82%-2.31M9.08%-1.81M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-0.81%